Litcius/Paper detail

Resistance mutations in SARS-CoV-2 omicron variant after tixagevimab-cilgavimab treatment

Camille Vellas, Nassim Kamar, Jacques Izopet

2022Journal of Infection31 citationsDOIOpen Access PDF

Topics & Concepts

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Coronavirus disease 2019 (COVID-19)2019-20 coronavirus outbreakVirologyBetacoronavirusMutationMedicineBiologyGeneticsGeneInternal medicineDiseaseInfectious disease (medical specialty)OutbreakSARS-CoV-2 and COVID-19 ResearchCAR-T cell therapy researchImmunotherapy and Immune Responses
Resistance mutations in SARS-CoV-2 omicron variant after tixagevimab-cilgavimab treatment | Litcius